Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael L Pearl

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2020
Carboplatin and Paclitaxel for Advanced Endometrial Cancer: Final Overall Survival and Adverse Event Analysis of a Phase III Trial (NRG Oncology/GOG0209)David S Miller, Virginia L Filiaci, Robert S Mannel, et al.
Gynecologic Oncology|October 4, 2017
Dysregulation of miR-181c expression influences recurrence of endometrial endometrioid adenocarcinoma by modulating NOTCH2 expression: An NRG Oncology/Gynecologic Oncology Group studyEric J Devor, Jeffrey Miecznikowski, Brandon M Schickling, et al.
Gynecologic Oncology|April 11, 2017
Surgical-pathological findings in type 1 and 2 endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study on GOG-210 protocolWilliam T Creasman, Shamshad Ali, David G Mutch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2021
A Surgical Window Trial Evaluating Medroxyprogesterone Acetate with or without Entinostat in Patients with Endometrial Cancer and Validation of Biomarkers of Cellular ResponseLinda R Duska, Virginia L Filiaci, Joan L Walker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2016
Clinicopathologic Significance of Mismatch Repair Defects in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group StudyD Scott McMeekin, David L Tritchler, David E Cohn, et al.
American Journal of Obstetrics and Gynecology|August 11, 2018
Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 StudyAshley S Felix, David E Cohn, Theodore M Brasky, et al.
Journal of the National Cancer Institute|April 5, 2017
Nonsteroidal Anti-inflammatory Drugs and Endometrial Carcinoma Mortality and RecurrenceTheodore M Brasky, Ashley S Felix, David E Cohn, et al.
Gynecologic Oncology|November 15, 2017
An NRG Oncology/GOG study of molecular classification for risk prediction in endometrioid endometrial cancerCasey M Cosgrove, David L Tritchler, David E Cohn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 11, 2015
Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group StudyPaul J Goodfellow, Caroline C Billingsley, Heather A Lankes, et al.
Molecular Cancer Therapeutics|August 28, 2020
Circulating Tumor Cells In Advanced Cervical Cancer: NRG Oncology-Gynecologic Oncology Group Study 240 (NCT 00803062)Krishnansu S Tewari, Michael W Sill, Bradley J Monk, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2020
Carboplatin and Paclitaxel for Advanced Endometrial Cancer: Final Overall Survival and Adverse Event Analysis of a Phase III Trial (NRG Oncology/GOG0209)David S Miller, Virginia L Filiaci, Robert S Mannel, et al.
Gynecologic Oncology|October 4, 2017
Dysregulation of miR-181c expression influences recurrence of endometrial endometrioid adenocarcinoma by modulating NOTCH2 expression: An NRG Oncology/Gynecologic Oncology Group studyEric J Devor, Jeffrey Miecznikowski, Brandon M Schickling, et al.
Gynecologic Oncology|April 11, 2017
Surgical-pathological findings in type 1 and 2 endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study on GOG-210 protocolWilliam T Creasman, Shamshad Ali, David G Mutch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2021
A Surgical Window Trial Evaluating Medroxyprogesterone Acetate with or without Entinostat in Patients with Endometrial Cancer and Validation of Biomarkers of Cellular ResponseLinda R Duska, Virginia L Filiaci, Joan L Walker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2016
Clinicopathologic Significance of Mismatch Repair Defects in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group StudyD Scott McMeekin, David L Tritchler, David E Cohn, et al.
American Journal of Obstetrics and Gynecology|August 11, 2018
Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 StudyAshley S Felix, David E Cohn, Theodore M Brasky, et al.
Journal of the National Cancer Institute|April 5, 2017
Nonsteroidal Anti-inflammatory Drugs and Endometrial Carcinoma Mortality and RecurrenceTheodore M Brasky, Ashley S Felix, David E Cohn, et al.
Gynecologic Oncology|November 15, 2017
An NRG Oncology/GOG study of molecular classification for risk prediction in endometrioid endometrial cancerCasey M Cosgrove, David L Tritchler, David E Cohn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 11, 2015
Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group StudyPaul J Goodfellow, Caroline C Billingsley, Heather A Lankes, et al.
Molecular Cancer Therapeutics|August 28, 2020
Circulating Tumor Cells In Advanced Cervical Cancer: NRG Oncology-Gynecologic Oncology Group Study 240 (NCT 00803062)Krishnansu S Tewari, Michael W Sill, Bradley J Monk, et al.
Pageof 7